Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 2,016.00
-12.70 (-0.63%)
Nov 12, 2026, 3:30 PM IST
Dr. Lal PathLabs Revenue
Dr. Lal PathLabs had revenue of 8.74B INR in the quarter ending September 30, 2026, with 19.61% growth. This brings the company's total for the last twelve months to 30.34B, up 16.71% year-over-year. In the fiscal year ending March 31, 2026, Dr. Lal PathLabs had annual revenue of 27.63B with 12.25% growth. That makes Dr. Lal PathLabs the 13,998th largest company in the world by revenue and 704th in India.
Revenue (ttm)
30.34B
Revenue Growth
+16.71%
P/S Ratio
11.11
Revenue / Employee
5.83M
Employees
5,206
Market Cap
337.22B
Revenue by Geography
- India 27.41B 99.2%
- Outside India 214.45M 0.8%
Fiscal year ended Mar 31, 2026 See the full Dr. Lal PathLabs breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 27.63B | 3.02B | 12.25% |
| Mar 31, 2025 | 24.61B | 2.35B | 10.54% |
| Mar 31, 2024 | 22.27B | 2.10B | 10.40% |
| Mar 31, 2023 | 20.17B | -705.26M | -3.38% |
| Mar 31, 2022 | 20.87B | 5.06B | 32.01% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 616.31B |
| Divi's Laboratories | 121.91B |
| Lenskart Solutions | 103.83B |
| Narayana Hrudayalaya | 102.73B |
| Piramal Pharma | 97.79B |
| Laurus Labs | 78.23B |
| Global Health | 50.53B |
| Krishna Institute of Medical Sciences | 45.96B |
Dr. Lal PathLabs News
- 8 days ago - Dr. Lal PathLabs Transcript: Q2 26/27 - Transcripts
- 8 days ago - Dr. Lal PathLabs Quarterly report: Q2 2027 - Filings
- 8 days ago - Dr. Lal PathLabs Slides: Q2 2027 - Filings
- 8 days ago - India's Dr Lal PathLabs posts higher quarterly profit on strong diagnostic test demand - Reuters
- 3 months ago - Dr. Lal PathLabs Transcript: Q1 26/27 - Transcripts
- 3 months ago - Dr. Lal PathLabs Quarterly report: Q1 2027 - Filings
- 3 months ago - Dr. Lal PathLabs Slides: Q1 2027 - Filings
- 3 months ago - India's Dr Lal PathLabs posts higher first-quarter profit on healthy demand for tests - Reuters